.png)
Auxilius began with one clear goal: Help biopharma sponsors bring therapies to market more cost-effectively. By working closely with customers, we built and scaled our initial clinical trial accruals solution, in the process uncovering a web of interconnect challenges holding clinical finance teams back from achieving their full potential. This partnership with customers has also made it clear where we needed to go next.
Today, we’re proud to introduce the next evolution of Auxilius: A suite of four new innovations built to give sponsors greater control over their R&D budgets, more transparency from first patient to study close-out, and more confidence navigating their organization’s growth. These are capabilities we’ve collaborated on closely with customers and partners, and we’re excited to announce them to the broader community.
Keep reading to learn more, or reach out here to get live Auxilius Product Event recording.
A purpose-built solution for managing investigator spend, end to end.
We heard it again and again: Investigator spend is one of the hardest areas to manage—and one of the biggest sources of risk.
That’s why we developed the Auxilius Investigator Suite, a standalone solution designed to give sponsors full control and transparency over investigator costs, including:
It's the only tool of its kind built specifically for the complexities of clinical trial investigator spend, and brings it all together in one integrated, auditable workflow.
Early customers have seen several benefits:
Be on the look-out for us to expand into site payments in the near future as well!
Identify variances between internal estimates and CRO billing - without the extra manual work.
Validating the accuracy of site payments has long been an incredibly manual, time-consuming process, forcing teams to choose between spot-checking payments reports or spending weeks on amore comprehensive reconciliation.
Investigator Reconciliation (IR) changes that. As part of our Investigator Suite, IR uses intelligent data matching to automatically validate site payments against structured clinical activity data in the Auxilius system. IR not only identifies site overbilling and duplicate billing, it also allows teams to tailor their accrual models to get more accurate over time.
How it works:
Reporting available through Investigator Reconciliation
One early customer identified over $100,000 in duplicate payments from a single study with Investigator Reconciliation!
Accommodate complexity beyond the clinic.
While Auxilius was originally built to solve clinical trial finance, we know that challenges don’t stop at trial boundaries.
CMC (Chemistry, Manufacturing, andControls) budgets introduce their own set of hurdles: Large vendor counts, shifting scopes, and a constant stream of POs and change orders. To better support these workflows, we’ve evolved Auxilius to handle the nuances of non-clinical cost types—including vendor tracking, invoice management, and financial close.
These enhancements give your team the flexibility and visibility to manage diverse cost categories—all within asingle, connected platform.
Transforming clinical finance. Together.
Modernizing clinical trial finance doesn’t happen in a vacuum. It’s often part of a broader finance transformation spanning systems, processes, and people.
To support that, we’re formalizing a network of collaborators we’ve long trusted behind the scenes: Auxilius Strategic Alliance Partners. This vetted group of consulting, advisory, and technology firms brings deep expertise in areas like:
What makes these partners different? They’re not just domain experts—they’re trained and enabled in Auxilius, with a proven track record of success alongside our customers. They know how Auxilius fits into the bigger picture and how to help you get the most from it.
These new innovations mark an important milestone in our journey, but they’re just the beginning. At Auxilius, we remain committed to building with and for our customers, solving real problems critical to clinical finance.
Thanks to all our customers, partners, and team members who helped shape this next chapter. We’re excited for what’s ahead.
Stay up to date with what is new in our industry, learn more about the upcoming products and events.
